Cytokine engineered NK-92 therapy to improve persistence and anti-tumor activity

Natural killer (NK) cells are an attractive cell source in cancer immunotherapy due to their potent antitumor ability and promising safety for allogenic applications. However, the clinical outcome of NK cell therapy has been limited due to poor persistence and loss of activity in the cytokine-defici...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Hyun Young, Jang, Seil, Woo, Hyeong Jung, Chung, Jae-Hee, Kim, Woon-Hae, Kim, Dongoh, Kang, Minju, Lim, Yujin, Habib, Omer, Lee, Jungmin, Yang, Sohae, Lee, Dae Hee, Kim, Minseok S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086201/
https://www.ncbi.nlm.nih.gov/pubmed/37056568
http://dx.doi.org/10.7150/thno.79942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086201/
https://www.ncbi.nlm.nih.gov/pubmed/37056568
http://dx.doi.org/10.7150/thno.79942

Ejemplares similares